Ex Parte SMITH - Page 6


                 Appeal No. 1996-0605                                                                                   
                 Application 07/989,593                                                                                 




                 vitamin E and C must both be distributed within the liposome.  See, e.g.,                              
                 Specification, Figure 8.  While the examiner is correct in that the fat-soluble                        
                 vitamin E (alpha-tocopherol) will not sequester in the aqueous interior of the                         
                 liposome, vitamin C (ascorbic acid) certainly will.  See, Specification, Figure 8.                     
                 Since, as recognized by the examiner, Lichtenberger teaches liposomal                                  
                 compositions containing antioxidants E and C, we are confronted with the                               
                 problem of where Lichtenberger’s vitamin C is found if not in the aqueous interior                     
                 of the liposome.                                                                                       
                        The Stone Declaration provides the answer.  Page 2 of the Stone                                 
                 Declaration states, “[m]oreover, Lichtenberger at column 21, lines 65-68                               
                 suggests that the antioxidants would be added to the diluent and, therefore,                           
                 water soluble vitamins would not be encapsulated into any liposomal                                    
                 preparations.”  Specifically, Lichtenberger discloses,                                                 

                               However, for most applications it will generally be                                      
                               desirable to provide the lipids in the form of a colloidal                               
                               or liposomal suspension of the selected composition                                      
                               in an pharmaceutically acceptable aueous diluent.                                        
                               While virtually an[y] pharmaceutically acceptable                                        
                               aqueous diluent may be employed, it has generally                                        
                               been found that a certain salt, for example in the form                                  
                               of isotonic saline has significant anti-ulcer activity.                                  
                               Further, small amounts of heavy metals (or other                                         
                               polyvalent cations) or anti-oxidant chemicals with the                                   
                               capability of scavenging free radicals can be added to                                   
                               the diluent to provide a lipid composition of greater                                    
                               anti-ulcer efficacy, stability and lumen-coating                                         
                               effectiveness.                                                                           


                                                                  6                                                     



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007